{
    "URL": "https://doi.org/10.1371/journal.pntd.0012376",
    "Published": "August 22, 2024",
    "Subject_Areas": [
        "Dengue fever",
        "Vaccine development",
        "Vaccination and immunization",
        "Epidemiology",
        "Sri Lanka",
        "Mosquitoes",
        "Hospitalizations",
        "Vaccines"
    ],
    "Authors": {
        "LakKumar Fernando": [
            "Centre for Clinical Management of Dengue & Dengue Haemorrhagic Fever, Negombo General Hospital, Negombo, Sri Lanka"
        ],
        "Randee Kastner": [
            "Takeda Vaccines, Inc., Boston, Massachusetts, United States of America"
        ],
        "Pujitha Wickramasinghe": [
            "University of Colombo, Colombo, Sri Lanka"
        ],
        "Asvini D. Fernando": [
            "Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka"
        ],
        "Dulanie Gunasekera": [
            "Faculty of Medical Sciences, University of Sri Jayawardenenpura, Colombo, Sri Lanka"
        ],
        "Van Hung Nguyen": [
            "VHN Consulting, Montreal, Quebec, Canada"
        ],
        "Mengya Liu": [
            "Takeda Vaccines, Inc., Boston, Massachusetts, United States of America"
        ],
        "Inge LeFevre": [
            "Takeda Pharmaceuticals International AG, Zurich, Switzerland"
        ],
        "Derek Wallace": [
            "Takeda Vaccines, Inc., Boston, Massachusetts, United States of America"
        ],
        "Nicolas Folschweiller": [
            "Takeda Pharmaceuticals International AG, Zurich, Switzerland"
        ],
        "Shibadas Biswal": [
            "Takeda Vaccines, Inc., Boston, Massachusetts, United States of America"
        ]
    }
}